Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

The average age of men who get diagnosed is 67.

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer and found “small ...

Radiosurgery New York (RSNY) Demystifies Kinds of Prostate Cancer for Enhanced Patient Awareness NEW YORK, NY, USA, August 24, 2023/EINPresswire.com/ -- Radiosurgery ...

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

Experts urge caution in interpreting results of a small pilot study finding microplastics in prostate cancer tissue, calling the results provocative but preliminary.

A drug used to treat type 2 diabetes may also be used to treat prostate cancer. The corresponding study was published in Molecular Cancer. "This is a significant discovery. For the first time, we have ...

Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...